electroCore Inc

43E0

Company Profile

  • Business description

    electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

  • Contact

    200 Forge Way
    Suite 205
    RockawayNJ07866
    USA

    T: +1 973 290-0097

    E: [email protected]

    https://www.electrocore.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    62

Stocks News & Analysis

stocks

Are declining Chinese births a red flag for A2 Milk?

Demographic challenges in A2’s largest market lead to sell-off.
stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.5010.100.11%
CAC 408,062.5849.44-0.61%
DAX 4024,703.12255.94-1.03%
Dow JONES (US)48,488.59870.74-1.76%
FTSE 10010,126.7868.57-0.67%
HKSE26,456.0731.44-0.12%
NASDAQ22,954.32561.07-2.39%
Nikkei 22552,693.43297.67-0.56%
NZX 50 Index13,430.09143.84-1.06%
S&P 5006,796.86143.15-2.06%
S&P/ASX 2008,781.9013.000.15%
SSE Composite Index4,133.3719.720.48%

Market Movers